Steris (STE) Liabilities from Discontinued Operations (2023 - 2024)
Steris' quarterly Liabilities from Discontinued Operations came in at 64012000.0 in Q1 2024, up 205.75% year-on-year from 20936000.0 in Q2 2023, and up 205.75% quarter-over-quarter from 20936000.0 in Q1 2023.
Steris has reported Liabilities from Discontinued Operations for 2 years, with the latest figure at 64012000.0 in Q1 2024.
- For the quarter ending Q1 2024, Liabilities from Discontinued Operations rose 205.75% year-over-year to 64012000.0; the trailing twelve-month figure through Mar 2024 stood at 64012000.0 (up 205.75% YoY), and the FY2024 full-year result was 64012000.0, up 205.75% from the prior year.
- Liabilities from Discontinued Operations for Q1 2024 stood at 64012000.0, up from 20936000.0 in the prior quarter.
- The five-year high for Liabilities from Discontinued Operations was 64012000.0 in Q1 2024, with the low at 20936000.0 in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 64.01 Mn |
| Mar 31, 2024 | 64.01 Mn |
| Mar 31, 2023 | 20.94 Mn |
| Mar 31, 2023 | 20.94 Mn |